Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Ustekinumab vs Risankizumab in Crohn’s — Dan Joseph Stein (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Ustekinumab vs Risankizumab in Crohn’s
Shared by
Dan Joseph Stein
Ustekinumab vs Risankizumab in Crohn’s
Chapter In A Book
2023
en
Authors
Dan Joseph Stein
SF
Salina Faidhalla
Related publications
Article
2019
Risankizumab vs. ustekinumab for plaque psoriasis
Ali Al‐Janabi
,
Zarif K. Jabbar‐Lopez
,
Christopher Em Griffiths
,
Zenas Z N Yiu
Article
2019
Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal
Ali Al‐Janabi
,
Zarif K. Jabbar‐Lopez
,
Christopher Em Griffiths
,
Zenas Z N Yiu
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2025
S5005 Esophageal Crohn’s Disease Successfully Treated With Risankizumab: A Case Series
Taylor Hallcox
,
Dan Joseph Stein
Article
2019
适用于斑块状银屑病的 risankizumab 与 ustekinumab:严格评读
Ali Al‐Janabi
,
Zarif K. Jabbar‐Lopez
,
Christopher Em Griffiths
,
Zenas Z N Yiu
Article
2023
Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn’s Disease
Haixia Ren
,
Jian Jian Kang
,
Jing Wang
,
Juan Su
,
Li‐Ping Zou
,
Anning Yin
,
Jiao Li
,
Qian Zhou
,
Wei Wang
,
Zhishun Tang
,
Jing Zhang
,
Yueyue Lu
,
Yuanping Yang
,
Chengen Qiu
,
Yijuan Ding
,
Weiguo Dong
,
Ping An
Discussion(0)
No comments yet. Be the first to comment.